Registration

FOLEY & LARDNER LLP for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market.

LobbyistCovered position, as disclosed
JENNIFER FITZGERALD WALSH New Administrative Assistant, Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Assistant, Program Director, Executive Assistant: House Democratic Caucus

Health Issues HCR

FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market.

LobbyistCovered position, as disclosed
JENNIFER FITZGERALD WALSH New Administrative Assistant, Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Assistant, Program Director, Executive Assistant: House Democratic Caucus

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ENDO INTERNATIONAL PLC Ireland Ireland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.